New CMS Rules, Team Models & Proposed Cuts: What It All Means for Your Home Health Agency’s Valuation

The home health sector is moving into a new era. Between evolving CMS rules, the push toward a
team-based care model, and MedPAC’s recommendation for a
7% home health payment cut in 2027, agencies are being asked to deliver more coordination,
documentation, and quality—often while being paid less.

If you own a home health, hospice, or home care agency, the real question isn’t just
“what does the rule say?” It’s:

• How will these changes affect how much my home health agency is worth?
• Should I consider selling before these cuts and models fully hit my margins?
• What does this do to valuation multiples and buyer appetite?

At Vallexa Advisors, we work exclusively with healthcare business owners on valuation and exit strategy.
We’re already modeling how these shifts are changing risk, value, and timing for sellers who are searching
for answers like “home health valuation,” “sell my home health agency,” or “how much is my home care business worth?”

---

The CMS “Team Model” – Why It Matters for Sellers

Coverage from Home Health Care News highlights how providers are preparing for a more formal
team-based care model under CMS. In practice, this means:

• More structured coordination between nurses, therapists, social workers, and aides
• Stronger clinical leadership expectations
• Higher documentation standards to prove collaboration and quality
• Increased operational oversight tied to reimbursement and quality scores

For owners, the impact is clear: operational complexity is increasing.
That complexity affects staffing, training, supervision, technology, and documentation—all of which influence
how a buyer views your risk profile and ultimately your valuation.

---

MedPAC’s Proposed 7% Payment Cut for 2027

In December 2025, MedPAC signaled it will recommend a 7% reduction to 2027 home health payment rates,
according to reporting from
Home Health Care News.
This is on top of prior cuts and adjustments that providers have already absorbed.

Why does that matter if you’re thinking about selling your home health or home care agency?
Because buyers underwrite deals based on future earnings and risk, not just today’s numbers.
A sustained downward trend in reimbursement:

• Puts pressure on EBITDA and cash flow
• Forces buyers to model more conservative scenarios
• Can compress valuation multiples for agencies that cannot demonstrate strong operations
• Hits smaller, rural, or single-location agencies especially hard

For agency owners actively searching “home health valuation,” “sell my home health agency,” or “how much is my home health worth,”
these trends are not background noise—they are direct inputs into your value.

---

How New CMS Rules Influence Your Agency’s Valuation

1. EBITDA Will Be Under a Microscope

Payment changes and increased documentation burden mean that buyers will scrutinize your earnings more than ever.
Agencies that see margins shrinking without a clear plan to adapt may face lower offers or longer diligence.
On the other hand, agencies that can show stable or improving EBITDA in this environment will stand out.

• Clean, accurate financials with clear add-backs
• Evidence of sustainable margins despite reimbursement pressure
• Visibility into visit utilization, payer mix, and overhead

If you’re wondering “how much is my home health worth?” the first step is understanding your true, normalized EBITDA
under today’s rules and tomorrow’s risk.

2. Operational Strength Becomes a Valuation Multiplier

Under the Team Model and tightening oversight, buyers are looking for agencies that are not only compliant but
operationally disciplined. This includes:

• Well-defined clinical leadership and team structures
• Consistent policies and procedures that are actually followed
• Audit-ready documentation for PDGM, LUPA, and face-to-face requirements
• Reliable scheduling, staffing, and referral management processes

Agencies that demonstrate this kind of operational maturity can still command strong valuations—even in a
climate of cuts—because they are seen as safer and more scalable platforms.

3. Team Stability Drives Buyer Confidence

As CMS leans further into team-based care, the value of a cohesive, stable team has never been higher.
Buyers pay close attention to:

• Turnover among key clinical staff
• Depth of management and clinical leadership
• Reliance on contract or temp labor
• Culture indicators: communication, retention, and engagement

A stable team signals that your agency can adapt to regulatory change—and that reduces perceived risk when buyers
evaluate whether to acquire, roll up, or partner with your organization.

4. Timing Your Exit Becomes Strategic

Owners often ask:

• “Is it better to sell my home health agency before more CMS cuts hit?”
• “Will waiting a few years increase or decrease my value?”

There is no one-size-fits-all answer, but historically selling before structural payment changes fully reset the market
has been advantageous for many operators—especially those with strong metrics today. Waiting too long can mean
selling into a market where multiples and expectations have already adjusted downward.

---

What To Do If You’re Considering Selling in the Next 1–3 Years

If you own a home health, hospice, or home care agency and you are thinking about selling in the next 12–36 months,
here are practical steps you can take now to protect and potentially increase your valuation.

1. Get a Realistic Valuation Baseline

Start by understanding where you stand today. Instead of relying on generic rules-of-thumb or informal advice,
get a valuation that accounts for CMS changes, PDGM risk, staffing, and your specific market. Knowing your real
baseline helps you make smart decisions about timing and preparation.

2. Tighten Documentation and Compliance

With the Team Model and ongoing CMS scrutiny, documentation is now a valuation asset. Focus on:

• Face-to-face documentation accuracy
• PDGM-compliant coding and OASIS accuracy
• LUPA management and justifications
• Clear clinical policies and QA/QI programs

Agencies that can demonstrate clean, consistent documentation are far more attractive to risk-aware buyers.

3. Fix Operational Inefficiencies Before Buyers See Them

Many value-draining issues can be addressed in a matter of months:

• Scheduling inefficiencies and unproductive travel
• Claim denials and billing delays
• Referral concentration risk
• Underutilized staff or fragmented coverage areas

Even modest improvements in these areas can have an outsized effect on the offers you receive when it is time to sell.

4. Explore the Market Quietly with a Healthcare-Focused Advisor

You don’t need to list your agency publicly to start shaping your exit. A confidential conversation with a
healthcare-focused M&A advisor can help you understand:

• How buyers are valuing agencies like yours in the current environment
• What changes could make a meaningful difference in your valuation
• What a realistic timeline looks like—under new CMS rules and proposed cuts

That’s where Vallexa Advisors comes in.

---

Why Vallexa Advisors Is a Strategic Partner in This New CMS Era

Generic business brokers are not equipped to navigate the details of CMS rule changes, PDGM, MedPAC
recommendations, and healthcare-specific diligence. Vallexa Advisors focuses on:

• Selling home health, hospice, and home care agencies nationwide
• Understanding how reimbursement changes translate into valuation
• Crafting a clear story for buyers around your operations, team, and compliance
• Helping you time and structure your exit to align with your goals

Our mission is simple: help healthcare owners protect the value they built—then exit on their terms.

If you’re asking “how much is my home health worth?”, “should I sell my home care agency?”, or
“how do I sell my home health agency in this CMS environment?”, you don’t have to figure it out alone.

Frequently Asked Questions About New CMS Rules & Selling Your Home Health Agency

Will the new CMS rules and proposed cuts lower the value of my home health agency?

They can, but not automatically. Agencies with weak documentation, thin margins, and limited operational discipline are most at risk. Agencies that show strong EBITDA, clean compliance, and stable teams can still command strong valuations even in a tighter reimbursement environment. The key is preparing early and understanding how buyers will underwrite your specific risk profile.

Is now a good time to sell my home health or hospice agency?

The best time to sell is when your agency is performing well and you still have energy to run it through a sale process. With MedPAC recommending further cuts and CMS leaning into team-based models, many owners are choosing to evaluate their options sooner rather than later. A confidential valuation and strategy review can help you decide whether you should sell now, improve first, or wait.

How do buyers look at the CMS Team Model when valuing my business?

Buyers are paying closer attention to how your teams function in practice. They look at clinical leadership, communication across disciplines, supervision, compliance processes, and the stability of your staff. Agencies that already operate like a coordinated team under today’s standards are better positioned for the Team Model and can look less risky to buyers.

What should I fix first if I want to improve my valuation?

Start with the areas that most directly affect buyer confidence: accurate financials, clean documentation, and staffing stability. Make sure your financial statements are organized, your PDGM and billing practices are defensible, and your team structure is clear. From there, work on referral diversity and operational efficiency. A healthcare M&A advisor can help you prioritize what matters most in your specific market.

Do I need a healthcare-focused M&A advisor, or can I sell the agency myself?

You can try to sell on your own, but most owners find that a healthcare-focused advisor saves time, reduces stress, and protects value—especially in a changing CMS environment. An advisor like Vallexa coordinates buyers, manages diligence, frames your story in language buyers understand, and helps you navigate negotiation and closing while you continue to run the agency.